News and Research
Immune System
Researchers Find Plant Immune System's 'Take Two Aspirin'
Gene, Offering Hope For Disease Control Without Agricultural
Pesticides
12-9-2003
ITHACA, N.Y. -- Scientists have found the gene that sends
a signal through plant immune systems, saying, in effect:
"Take two aspirin and call out the troops – we're
under attack!"
Discovery
of the salicylic acid-binding protein 2 (SABP2) gene, by
scientists at Boyce Thompson Institute for Plant Research
(BTI) at Cornell University, is being called an important
step toward new strategies to boost plants' natural defenses
against disease and for reducing the need for agricultural
pesticides.
Salicylic
acid, the chemical compound found naturally in most plants
(as well as in the most-used medication, aspirin), is a
plant hormone produced at elevated levels in response to
attack by microbial pathogens. According to a report on
the Web today in the Proceedings of the National Academy
of Sciences (PNAS Early Edition, week of Dec. 7, 2003) by
BTI's Dhirendra Kumar and Daniel F. Klessig, the aspirin-like
hormone is perceived by the SABP2 protein and a message
is transmitted, via a lipid-based signal, to activate the
plant's defense arsenal. Says Klessig, "Now that we
know a key signaling protein in plant immune systems, we
can work on ways to enhance the signal and help plants fight
disease without using potentially harmful pesticides."
The
PNAS authors say SABP2 plays an important role in restricting
infections by inducing host cells at the site of infection
to undergo programmed cell death and sacrifice themselves
for the benefit of the rest of the plant.
|
|
SABP2 also plays a critical role in activating the
innate immune system in other parts of the plant to guard against
further attack or spread by the same pathogen – and even against
unrelated pathogens. (Innate immune systems, which mount an immediate
defense against infections, are found in all plants and animals. But
only vertebrates, including humans and other mammals, have additional
levels of defense – the antibody-producing B cell and T cell-mediated
acquired immunity for a delayed response that can take weeks to develop.)
The Klessig laboratory discovered the presence of
the SABP2 protein in plants in 1997. But it took five years to purify
the protein, which occurs naturally in "excruciatingly small
amounts," then to clone the gene that encodes it, and finally
to assess the role of SABP2 in disease resistance. The PNAS article
tells how the researchers proved that SABP2 is a key player in innate
immunity by silencing the SABP2 gene and watching the plant immune
system fail.
Although the salicylic acid-signaling experiments
were done with tobacco plants – because tobacco is a well-known
plant species for studying disease resistance – similar salicylic
acid-binding proteins are found in other plant species, the BTI researchers
say, making their results applicable to other crop plants.
And the finding might even help immunologists understand
evolutionarily related signaling pathways in vertebrates, including
humans, according to another BTI researcher and professor of plant
pathology at Cornell, Gregory B. Martin. In a 2001 research article,
he suggested that some molecular mechanisms involved in innate immunity
in mammalian and insect systems "are remarkably similar to the
molecular mechanisms underlying plant disease-resistance responses."
Innate immunity in all kinds of living things, Martin and his co-authors
added, "might be an evolutionarily ancient system of host defense."
When tobacco mosaic virus attacks a tobacco plant,
the PNAS authors report, the immediate visible effect of SABP2 is
to enable salicylic acid to induce the so-called hypersensitive resistance
response. "We see programmed cell death at the site of the attack
as plant cells sacrifice themselves for the overall survival of the
plant," Klessig explains. "We believe programmed cell death
helps restrict the infection to a small part of the plant. Something
similar happens in animal systems, when virus-infected cells or cells
with defective growth control that could become cancerous undergo
programmed cell death," he says, noting that aspirin has been
found to have a protective effect against cancer.
Even as the infection is being contained, the plant
begins to signal other parts of itself that it is undergoing attack.
"This leads to long-lasting, broad-spectrum systemic resistance
to infections against the initial attacking pathogen and also against
other viral, bacterial and fungal pathogens," Klessig says. "Systemic
acquired resistance can last throughout most of the life of an annual
plant."
Earlier this year the Klessig research group announced
(in the May 16, 2003, issue of the journal Cell) their discovery of
a plant gene for nitric oxide synthase, the enzyme that rapidly produces
nitric oxide (NO) after infection. This is one of the earliest responses
to pathogen attack.
"With nitric oxide synthase and now with SABP2,
as well as other defense-signaling pathway components that have already
or are sure to be discovered, we are beginning to see some effective
and sustainable alternatives to pesticides," Klessig says, suggesting
two possible strategies:
Genetic manipulation could enhance a crop plant's
ability to make more of a scarce defense-signaling compound or a limiting
receptor needed to transmit this signaling compound. Alternatively,
crops could be treated with a functional mimic of the signaling compound
itself when plant disease is anticipated.
"Either way, we are utilizing and enhancing a
plant's own natural defenses," Klessig says. "That should
be a better way, both because it will be much more difficult for pathogenic
organisms to develop resistance and because we can avoid contaminating
the environment."
He adds that an attack by a plant pathogen "marks
the start of a war. If the plant can recognize the pathogen and activate
its defense arsenal in time, the plant usually wins. But if the pathogen
circumvents detection or the defenses themselves, the plant is in
trouble. The more we learn about plant immune systems, the better
are the chances we can help important crop plants win their war –
without the collateral damage from chemical pesticides."
Klessig is president of BTI, an independent, not-for-profit
organization located on the Cornell campus, and an adjunct professor
of plant pathology; Kumar is a BTI research associate. The salicylic
acid-binding protein research was supported by the National Science
Foundation and by a plants and human health grant from the Triad Foundation.
This article has been adapted from a news release
issued by Cornell University, www.cornell.edu.
Next - Back
to Immune System Support